• drapreau en
  • drapreau fr


  • Preliminary
  • Scientific programme

    February 5, 2018 (9h00-12h00 A.M.) Metastasis and microenvironment – Metabolism  
    Metastasis & microenvironment
    Klaus Pantel (University Medical Center Hamburg-Eppendorf)

    Metabolism
    Pierre Sonveaux (Université Catholique de Louvain)
    Matthew G Vander Heiden (MIT)
    Jean-Emmanuel Sarry (Cancer Research Center of Toulouse)

    February 5, 2018 (14h00-17h00 P.M.) Genetic instability and DNA damage response
    Jan Hoeijmakers (Erasmus University of Rotterdam)
    Steve Jackson (University of Cambridge)
    Mark O’Connor (Astra-Zeneca)
    Gaëlle Legube (Center for Integrative Biology, Toulouse)

    February 6, 2018 (9h00-12h00 A.M.) Epigenetics – Non coding genome and cancer
    With the support of
    Epigenetics (including epidemiology)
    Maarten van Lohuizen (The Netherlands Cancer Institute)

    Non-coding genome & cancer
    Ramiro Garzon (The Ohio State University)
    Maite Huarte (University of Navarra)
    François Payre (Center for Integrative Biology, Toulouse)


    February 6, 2018 (14h00-17h00 P.M.) Cancer Immunotherapy, from bench to bed
    Jolanda De Vries (Radboud University Nijmegen)
    Nathalie Rufer (University of Lausanne)
    Jean-Philippe Girard (Institute of Pharmacology and Structural Biology, Toulouse)


    February 7, 2018 (9h00-12h00 A.M.) New therapeutic strategies
    Combined therapies
    Julien Mazières (IUCT-Rangueil Larrey, Cancer Research Center of Toulouse)

    Radiotherapy – Proton therapy
    Jim Metz (University of Pennsylvania)
    Gillies McKenna (University of Oxford)


    February 7, 2018 (14h00-17h00 P.M.) Clinical research on Melanoma
    Richard Marais (Cancer Research UK Manchester Institute)
    Céleste Lebbé (Hôpital Saint-Louis, APHP) 
    Nicolas Meyer (IUCT-Oncopole, Cancer Research Center of Toulouse)